HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pastore, S. Articles by Girolomoni, G. Search for Related Content PubMed PubMed Citation Articles by Pastore, S. Articles by Girolomoni, G.

ERK1/2 Regulates Epidermal Chemokine Expression and Skin Inflammation¹

Saveria Pastore^2,*, Francesca Mascia^*, Feliciana Mariotti^*, Cristina Dattilo^*, Valentina Mariani^* and Giampiero Girolomoni^*,

^* Laboratory of Immunology, Istituto Dermopatico dell’Immacolata, Roma, Italy; and Department of Biomedical and Surgical Sciences, Section of Dermatology, University of Verona, Verona, Italy

Resident cell populations of the skin contribute to the inflammatory response by producing an array of chemokines, which attract leukocytes from the circulation. TNF- is a major inducer of proinflammatory mediators in keratinocytes. We have recently observed that epidermal growth factor receptor (EGFR) signaling affects TNF--driven chemokine expression in epidermal keratinocytes, and its functional impairment increases the levels of crucial chemoattractants such as CCL2/MCP-1, CCL5/RANTES, and CXCL10/IFN--inducible protein-10. In this study, we report evidence that EGFR-dependent ERK1/2 activity is implicated in this mechanism. Abrogation of ERK1/2 activity with specific inhibitors increased chemokine expression in keratinocytes by enhancing mRNA stabilization. In mouse models, inflammatory response to irritants and T cell-mediated contact hypersensitivity were both aggravated when elicited in a skin area previously treated with an EGFR or a MAPK kinase 1/2 inhibitor. In contrast, impairment of p38 MAPK phosphorylation markedly attenuated these responses. Our data indicate that EGFR-dependent ERK1/2 activity in keratinocytes takes part to a homeostatic mechanism regulating inflammatory responses, and emphasize the distinct role of MAPKs as potential targets for manipulating inflammation in the skin.

This article has been cited by other articles:

				S. Madonna, C. Scarponi, O. De Pita, and C. Albanesi Suppressor of cytokine signaling 1 inhibits IFN-{gamma} inflammatory signaling in human keratinocytes by sustaining ERK1/2 activation FASEB J, September 1, 2008; 22(9): 3287 - 3297. [Abstract] [Full Text] [PDF]

				P. A. Gerber, E. Enderlein, and B. Homey The Koebner-Phenomenon in Epidermal Growth Factor Receptor Inhibitor-Induced Cutaneous Adverse Effects J. Clin. Oncol., June 1, 2008; 26(16): 2790 - 2792. [Full Text] [PDF]

				H.-J. Cho, J. H. Kang, J.-Y. Kwak, T.-S. Lee, I.-S. Lee, N. G. Park, H. Nakajima, J. Magae, and Y.-C. Chang Ascofuranone suppresses PMA-mediated matrix metalloproteinase-9 gene activation through the Ras/Raf/MEK/ERK- and Ap1-dependent mechanisms Carcinogenesis, May 1, 2007; 28(5): 1104 - 1110. [Abstract] [Full Text] [PDF]